Krystal Biotech
Stock
Stock
ISIN: US5011471027
Ticker: KRYS
US5011471027
KRYS
Price
Price
CHART BY
Frequently asked questions
What is Krystal Biotech's market capitalization?
The market capitalization of Krystal Biotech is $4.74B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Krystal Biotech's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Krystal Biotech is 93.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Krystal Biotech?
Krystal Biotech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.768. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Krystal Biotech's stock?
Currently, 10 analysts cover Krystal Biotech's stock, with a consensus target price of $208.00. Analyst ratings provide insights into the stock's expected performance.
What is Krystal Biotech's revenue over the trailing twelve months?
Over the trailing twelve months, Krystal Biotech reported a revenue of $241.52M.
What is the EBITDA for Krystal Biotech?
Krystal Biotech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $71.54M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Krystal Biotech?
Krystal Biotech has a free cash flow of $58.06M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Krystal Biotech have, and what sector and industry does it belong to?
Krystal Biotech employs approximately 229 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Krystal Biotech's shares?
The free float of Krystal Biotech is 24.32M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $4.74B
- EPS (TTM)
- $1.768
- Free Float
- 24.32M
- P/E ratio (TTM)
- 93.25
- Revenue (TTM)
- $241.52M
- EBITDA (TTM)
- $71.54M
- Free Cashflow (TTM)
- $58.06M
Pricing
- 1D span
- $159.50$165.75
- 52W span
- $107.50$219.32
Analyst Ratings
The price target is $208.00 and the stock is covered by 10 analysts.
Buy
10
Hold
0
Sell
0
Information
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
- Employees
- 229
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US5011471027
- Primary Ticker
- KRYS